SCHEMBL6510098

SCHEMBL6510098

NC(=O)CCCCCn1cc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.42
TBXAS1 P24557 2/20 0.40
LTB4R Q15722 1/20 0.38
ICMT O60725 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PTGIR P43119 1/20 0.37
FABP4 P15090 1/20 0.37
FABP5 Q01469 1/20 0.37
HDAC1 Q13547 4/20 0.36
HDAC6 Q9UBN7 4/20 0.36
HDAC8 Q9BY41 3/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC10 Q969S8 2/20 0.36
HDAC11 Q96DB2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL608395 0.93 LMNA (0.49) LMNAKDM4ETBXAS1FABP4FABP5
SCHEMBL27801037 0.87 LMNA (0.54) LMNAKDM4EL3MBTL1MAPK1SMN1; SMN2
SCHEMBL6413325 0.86 FABP4 (0.51) TBXAS1MAPTPTGIRFABP4FABP5
SCHEMBL7633464 0.84 FABP4 (0.53) TBXAS1MAPTPTGIRFABP4FABP5
SCHEMBL931997 0.81 TBXAS1 (0.38) LMNATBXAS1L3MBTL1MAPTTDP1
Naphthalene SCHEMBL28057405 0.78 LMNA (0.47) LMNAKDM4ELTB4RL3MBTL1MAPT
Naphthalene SCHEMBL28931578 0.78 LMNA (0.50) LMNAKDM4ETBXAS1LTB4RL3MBTL1
SCHEMBL7365093 0.78 FABP4 (0.51) MAPTFABP4FABP5HDAC1HDAC6
SCHEMBL4960220 0.75 CA12 (0.42) LMNAKDM4EL3MBTL1MAPTTDP1
SCHEMBL9385329 0.73 CDK4 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953788-B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase AVENTIS PHARMACEUTICALS INC. (US) 2005-10-11 US claimed
EP-0928291-B1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMA INC (US) 2002-12-04 EP claimed
EP-0928291-A1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE HOECHST MARION ROUSSEL, INC. (US) 1999-07-14 EP claimed
WO-1998012211-A1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE HOECHST MARION ROUSSEL, INC. (US) 1998-03-26 WO claimed
US-6953788-B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase AVENTIS PHARMACEUTICALS INC. (US) 2005-10-11 US disclosed
EP-0928291-B1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMA INC (US) 2002-12-04 EP disclosed
EP-0928291-A1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE HOECHST MARION ROUSSEL, INC. (US) 1999-07-14 EP disclosed
WO-1998012211-A1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE HOECHST MARION ROUSSEL, INC. (US) 1998-03-26 WO disclosed